Liver disease in alcohol and hepatitis C. (Q35163806)

6 August 2017

1 reference

title

Liver disease in alcohol and hepatitis C. (English)

1 reference

6 August 2017

1 reference

M Mazen Jamal

1

1 reference

PubMed ID

12828960

6 August 2017

Timothy R Morgan

series ordinal

2

1 reference

6 August 2017

1 August 2003

1 reference

Best Practice and Research: Clinical Gastroenterology

6 August 2017

1 reference

6 August 2017

17

1 reference

6 August 2017

4

1 reference

6 August 2017

649-662

1 reference

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Trends in cirrhosis morbidity and mortality: United States, 1979-1988.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

High incidence of antibodies to hepatitis C virus in alcoholic cirrhosis: fact or fiction?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

High prevalence of antibody to hepatitis C virus in heavy drinkers with chronic liver diseases in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Interest of the detection of hepatitis C virus RNA in patients with alcoholic liver disease. Comparison with the HBV status

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Intravenous drug abuse--the major route of hepatitis C virus transmission among alcohol-dependent individuals?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Chronic hepatitis C in alcoholic patients: prevalence, genotypes, and correlation to liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Hepatitis C virus in alcoholic patients with and without clinically apparent liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Hepatitis C virus infection in patients with clinically diagnosed alcoholic liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Chronic hepatitis C: effect of alcohol on hepatitic activity and viral titre

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Serological and histological aspects of hepatitis C virus infection in alcoholic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

A case-control study of risk factors for sporadic hepatitis C virus infection in the southwestern United States

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

ESBRA 1997 Award lecture: relationship between excessive alcohol drinking and viral infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

The natural history of hepatitis C virus infection: host, viral, and environmental factors

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Effect of alcohol consumption on the progression of hepatitis C virus infection and risk of hepatocellular carcinoma in Japanese patients

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Impact of alcohol on the histological and clinical progression of hepatitis C infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Role of alcohol in the progression of liver disease caused by hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma--its relationship to alcohol drinking and the age of transfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

High malignancy of hepatocellular carcinoma in alcoholic patients with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Clinical course of hepatitis C virus during the first decade of infection: cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Outcome of hospital care of liver disease associated with hepatitis C in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Efficacy of interferon therapy in patients with chronic hepatitis C. Comparison between non-drinkers and drinkers

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Drinking habits of subjects with hepatitis C virus-related chronic liver disease: prevalence and effect on clinical, virological and pathological aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

Alcohol abstinence does not offset the strong negative effect of lifetime alcohol consumption on the outcome of interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900018-0

7 January 2021

10.1016/S1521-6918(03)00018-0

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12828960